Sickle cell stem cell harvest: a tiny step forward
NCT ID NCT02212535
First seen Nov 01, 2025 · Last updated Jun 13, 2026 · Updated 28 times
Summary
This early-phase study tested whether a single injection of plerixafor could safely and effectively mobilize stem cells for collection in 3 adults with severe sickle cell disease who lacked a matched sibling donor. The goal was to see if enough stem cells could be gathered for a future transplant. The study focused on safety and the number of stem cells collected, not on treating the disease itself.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR SICKLE CELL SYNDROME OF TYPE SS OR SΒ THALASSEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hôpital Necker - Enfants Malades
Paris, 75015, France
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.